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ABSTRACT 
Adenomatous Poliposis Coli (APC) anomalies are considered to playa gate-keeping role in colorectal 
tumorigenesis. Even though APC gene is extensively studied, there is a lack in effort towards creating a 
highly reproducible and less costly approach to diagnose APC anomalies. In this research, the APC cDNA 
fragments from the normal and tumour colorectal specimens are subjected to mutational analysis via 
restriction enzyme site characterization. Restriction digestions using AluI, HaeIII, Hinfl, HincH, HpaII, 
MboI, NdeI, RsaI, TaqI, and Trn9I were performed on all eight APC fragments of normal and tumour 
specimens accordingly. Restriction site map for the gene was constructed whereby assay on APC 2, APC 5, 
and APC 6 had generated differential restriction site pattern. Tumour APC 2 was showing aberrancy on RsaI, 
Hinfl, Trn9I, HaeIII, and HpaH; whereas tumour APC 5 was aberrant on AluI, and tumour APC 6 was 
aberrant on TaqI. This will facilitate the recognition of potential mutation marker to screen for APC 
aberrancy, allowing the comparative study between APC restriction site pattern of normal and tumour 
system. 
Key words: Adenomatous Poliposis Coli (APC) gene, tumour suppressor gene, restriction enzyme (RE) 
pattern, exon 15 
ABSTRAK 
Gen Adenomatous Poliposis Coli (APe) memainkan peranan penting dalam menyebabkan kejadian barah 
usus dan rektum. Walaupun banyak kajian telah dijalankan ke atas gen APe. usaha mengkaji mutasi APC 
dengan kaedah yang berkesan masih kekurangan. Dalam kajian ini, eDNA APC daripada sel usus normal 
dan tumor digunakan untuk analisis mutasi melalui pengenalpastian tapak enzim penghad. Kajian enzim 
pengehad telah dijalankan dengan menggunakan AluI, HaeIII, HinfI, Hind!, HpalI, Mbo!, NdeI, Rsal, TagI, 
dan Trn91 ke atas kelapan-lapan eDNA APC normal dan tumor. Pelan tapak enzim pengehad telan dibina, di 
mana APC 2, APC 5, dan APC 6 telah menunjukkan kelainan dalam kajian. Mutasi APC 2 ditemui pada 
tapak enzim penghad RsaI, Hinfl, Trn9I, HaeIII, dan HpaII; manakala mutasi APC 5 ditemui pada AluI, dan 
APC 6 pada Tag!. Kqjian ini akan membantu mengenalpasti eorak mutasi APC dan menyumbang kepada 
kajian perbandingan eorak tapak enzim penghad APC bagi sistem normal dan tumor. 
Kata kunci: Gen Adenomatous Poliposis Coli (APC), gen penindas tumor, eorak tapak enzim penghad, ekson 
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Colorectal cancer, or cancer of the large bowel, is commonly found around the 
western nation, afflicting the upper class of populations in the society. The disease often 
appears to be related to dietary factor, though hereditary predisposition element seems to 
play the major part. The occurrence of colorectal cancer has increased in the eastern 
society overtime, especially in Japan and Hong Kong, since the nation has adopted a more 
''western'' diet and lifestyle. Generally, the colorectal cancer occurs in individuals 50 
years ofage or older (Zaridze, 1982; Lipkin and Newmark, 1985). 
In the International Agency for Research on Cancer (lARC) statistics for the year 
2000, documented by Ferlay et al. (2001), colorectal carcinomas were catalogued as the 
third most common cause for cancer-related death worldwide. A total of 944,727 
colorectal cancer incidents were registered globally in 2000, of which 492,411 fatalities 
were accounted, issuing a global health concern. Cancer of the colon and rectum was 
ranked as the second leading killer in Malaysia, among the spectrum of cancer incidents 
diagnosed. For the year 2000, 2280 deaths were reported out of the 3528 co10rectal 
malignancies registered (Fer lay et al., 2001). This shows a significant increase in the 
prevalence of colorectal cancer cases from one year to another whereby only 239 cases 
were recorded in 1998 (Ministry ofHealth ofMalaysia, 1998; Chin, 2002). 
CHAPTER 2 
LITERATURE REVIEW 
2.1 Tumorigenesis of Colorectal Carcinomas 
Tumorigenesis of the colorectal regions is attributable to genetic aberrancies, which 
progresses through multistep processes (Vogelstein et at., 1988). Typically, the initial 
manifestation of the colorectal tumorigenesis commences with benign adenomatous crypts 
or polyps either in the colon or rectum. These crypts then multiply in a hyperproliferative 
manner, forming inflammatory masses, leading to malignant neoplasm. With the 
subsequent mutations of tumour suppressor genes, the early adenomas consequently 
develop into carcinomas and fmally metastasize upon more mutational occurences 
(Munemitsu et at., 1995; Russell, 2000; Tripathy, 2000). 
Colorectal carcmomas can be further categorized into hereditary and sporadic 
(non-hereditary) types. According to Knudson (1971), loss of heterozygosity (LOH) 
through the knockout of both alleles in tumour suppression genes leads to colo rect al 
metastasis. Individuals with genetic predisposition of colorectal cancer nonnally inherit 
single allele of mutated cancer-causing gene (or genes). Colorectal carcinogenesis 
develops when the remaining allele of tumour suppressor genes mutates, in accordance 
with Knudson's two-hit hypothesis (Knudson, 1971; Cave nee and White, 1995). 
Sporadic colorectal cancer, however, occurs only when genetic alteration takes place in 
both alleles of the cancer-causing genes. 
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In most cases, APC,j3-catenin (CTNNBl), Ki-ras (KRASl) oncogene, p53 (TP53) 
and DCC genes affect the different stages of colorectal carcinogenesis (Fearon and 
Vogelstein, 1990; Cavenee and White, 1995; Morin et al., 1997). Of these, APC 
anomalies are usually found in the initial stages of the adenoma-carcinoma pathway and 
are considered to playa gate-keeping role in tumour formation and progression (Powell et 
al., 1992). Pre-inactivation of both alleles of APC is considered to be crucial for 
colorectal tumorigenesis (Levy et al., 1994). 
2.2 Adenomatous Poliposis Coli (APC) Gene 
The Adenomatous Polyposis Coli (APC) is a tumour suppressor gene, localized at 
Chromosome 5 with a designated locus of 5q21-22 (Montera et al., 2001). It has a 
sequence of 8535 bp. The APC gene comprises 15 exons (Table 1), with an exceptionally 
large exon 15 spanning over 6.5kb (Dobbie et al., 1996). 
Table 1: The exons of the APe gene with the associated gene sequence as retrieved from 
the GenBank entries (Accession number NM_000038). 
Exon __________ ___________________ ~_xonE_x_on C_od_ing e_________ __ 
no. Coordinates Length Coordinates Length 
t 40-192 153bp 58-192 135bp 
2 193 - 277 85 bp 193 - 277 85 bp 
3 278-479 202bp 278-479 202bp 
4 480 - 588 109 bp 480 - 588 109 bp 
5 589 - 702 114 bp 589 - 702 114 bp 
6 703 - 786 84 bp 703 - 786 84 bp 
7 787-891 105bp 787-891 105bp 
8 892 - 990 99 bp 892 - 990 99 bp 
9 991 - 1369 379 bp 991 - 1369 379 bp 
10 1370 - 1465 96 bp 1370 - 1465 96 bp 
11 1466 - 1605 140 bp 1466 - 1605 140 bp 
12 1606-1683 78bp 1606-1683 78bp 
13 1684 - 1800 117 bp 1684 - 1800 117 bp 
14 1801 - 2015 215 bp 1801 - 2015 215 bp 
15 2016-10400 8385bp 2016-8589 6574bp 
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APC gene encodes a 2843-amino acid protein in its commonest isoform (Horii et 
al., 1993). The APC protein consists of an oligomerization region in the N-terminus, of 
which constitute the exon 1 and a partial of exon 2 of the APC gene (Figure 1). The 
Armadillo region, which shows a high degree of homology to the ~-catenin repeats, lies 
between the exon 10 and the S' region of exon IS. The APC domain central portion 
consists of a number of IS- and 20-amino acid repeats, which provide binding sites for 
p-catenin. The axin binding sites present within the region of the 20-amino acid repeats. 
The C-tenninus of APC contains a basic domain, EB 1 (a microtubule-associating protein) 
binding domain, and the human disc large (HDLG) protein binding sites (Fearnhead et al., 
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Figure I. The functional domains of APC protein. The asterisks indicate the SAMP 
repeats of ax in binding sites. Note that the 3' end of the mutation cluster region 
(MCR: codon 1286 - codon 1513) falls before the first axin binding site. Adapted 
from Fearnhead et al. (2001). The ABC of APe. Human Molecular Genetics. 10: 725. 
The fifteenth exon of APe comprises more than 7S% of the coding sequence, thus 
being the target for most germline and somatic mutations (Beroud and Soussi, 1996). 
Predominantly, the commonest germline mutations occur at codons 1061 and 1309, 
whereby such mutations accounted for a third of all germline mutations (Beroud and 
Soussi, 1996; Miyoshi et al. 1992). 
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2.3 APe and Colorectal Carcinomas 
According to Kinzler and Vogelstein (1996), functional lost of APe tumour 
suppressor gene is prominent in colorectal tumorigenesis. Germline anomalies in APe 
are accountable for most cases of hereditary colorectal cancer, familial adenomatous 
polyposis (FAP), while somatic defects in APe are found in approximately 80% of 
sporadic colorectal tumours (Fearnhead et al., 2001). 
The fact that APe is an integral part of so many different pathways makes it an 
ideal target for mutation in colorectal carcinogenesis. It engages in signalling 
transduction in the wnt-signalling pathway, mediation of intercellular adhesion, 
stabilization of the cytoskeleton and possibly regulation of the cell cycle and apoptosis 
(Fearnhead et ai., 2001). Despite having a wide range of functions, the most important role 
ofAPC in cancer genetics lies in its capacity to regulate the levels 0 f intercellular p-catenin 
(Albuquerque et al., 2002). 
Under normal circumstances, the APC protein encoded by APe gene forms 
complexes with glycogen synthase kinase 3p (GSK3P), p-catenin and proteins axin and 
conductin (Dihlmann, 1999), resulting in the degradation of p-catenin. Consequently, 
APC inactivates a variety of growth-promoting genes such as c-myc, cyclin Dl, matrilysin 
and c-jun, rendering inhibition to cell proliferation activities (Fujimori et al., 2001). 
Aberrancies inAPC (with prevalence of nonsense or frameshift mutations) almost 
ays result in a truncated protein product with anomalous function (Cottrell et al., 1992; 
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Nagase and Nakamura, 1993; Laken et at., 1999). In such situation, the initial role of 
APe protein in regulating ~-catenin is lost. Accumulation of /3--catenin and subsequent 
activation ofdownstream growth promoting genes will occur, leading to hyperproliferation 
ofcolor ectal cell (Fearnhead et at., 2001). 
APe gene is extensively studied, notably in the western continent where high 
prevalence of colorectal cancer cases is reported (The Cochrane CoUaboration, 2004). 
Intensive researches had been taken to look out for facts and useful fmdings that elucidate 
the implication ofAPC aberrancies towards colorectal carcinomas. Still, locally, there are 
fewer studies undertaken with regards to APe gene mutation and its relation to colorectal 
cancer. Additionally, there is a lack in effort that gears towards creating a highly 
reproducible and more cost-effective approach to diagnose APe anomalies. As stated by 
Stratchan and Read (2001), the cost-cutting and highly reproducible method of Restriction 
Fragment Length Polymorphism (RFLP) normally serves that purpose. The costly DNA 
sequencing procedure for mutation detection often limits its use. Through restriction 
enzyme (RE) site characterization, the restriction sites of mutated APC gene can be 
identified and compared with that of the normal APe gene. Differences in the restriction 
sites between normal and tumour APe gene can be manipulated as potential mutation 




In this research, the objective is to obtain the previously cloned normal APe cDNA 
Additionally, the tumour fragments will be isolated from the tumour colon 
imen and subjected to subcloning. Restriction enzyme digestion assay will be 
perfonned subsequently on both the normal and tumour samples. The APe RE patterns 
can be procured through the RE site characterization of cDNA fragments of APe gene 
taken from the colon tissue. This will later allow the comparative study between APe RE 




MATERIALS AND METHODS 

3.1 Materials 
The starting materials in this research are as follows: 
1. 	 eDNA fragment of APC gene in cloned system from the nonnal human colon tissue 
(courtesy ofWong, 1. J. L., Human Molecular Genetic Laboratory, VNlMAS). 
2. 	 Human colon tumour total RNA (colon adenocarcinoma isolated from a 43-year old 
female), were from BD Biosciences, Clontech (Cat.# 636634). 
3.2 Methods 
3.2.1 Procurement of Cloned cDNA of APe 
Colonies of pGEM®-T Easy Vectors (Promega, 2003) that had previously 
incorporated the desired eDNA fragments of APC gene (nonnal and tumour specimens) 
were inoculated into 5 ml of LB broth and incubated overnight with shaking at 200 rpm. 
Thereafter, plasmid isolation was perfonned following the protocol by Sambrook et al. 
(1989). 
Basically, 1.5 ml of fresh bacterial culture was pelleted by centrifugation at 13000 
rpm for 1 minute in 2 ml micro centrifuge tube whereby the supernatant was removed by 
ting. The cell pellet was then resuspended with 100 III of ice-cold Solution I (50 
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mM Glucose; 25 rnM Tris-HCl and 10 mM EDT A both at pH 8), mixed thoroughly by 
rigoruous vortexing and chilled subsequently. Then, 100).!1 of Solution II (0.2 N NaOH 
and I % SDS) was added to the cell suspension and mixed gently by inverting lOX. 
Subsequent chilling was performed for lysis reaction and should not exceed 5 minutes after 
which clear viscous liquid would be visible. Next, ice-cold Solution III (reaction of 5 M 
Potassium acetate, 11.5 % Glacial acetic acid and double-distilled H20 to top up) was 
added and mixed by invertion where white precipitate would be observed. The tube was 
chilled for 5 minutes and subjected to centrifugation at 10000 rpm for another 5 minutes. 
Consequently, the supernatant containing the plasmid was transferred into new 1.5 
ml micro centrifuge tube where 2 volume of cold absolute ethanol was added for DNA 
precipitation. After mixing, further centrifugation at 13000 rpm for 5 minutes was 
perfurmed. The supernatant was decanted and 500 ).!l of 70 % ethanol was applied to 
wash the pellet formed. Recentrifugation at 13000 rpm for 2 minutes was carried out 
with the supernatant decanted as much as possible, allowing the DNA pellet to air dry at 
room temperature for approximately 20 minutes. After resuspending and dissolving the 
DNA pellet in 30).!1 of sterile ultra pure water, the plasmid DNA solution was subjected to 
subsequent analysis including polymerase chain reaction (PCR). 
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3.2.2 Polymerase Chain Reaction (peR) 
PCR was perfonned to amplify the APe gene fragments either from normal or tumour 
specimens. A total of 8 pairs of specific peR primers (Table 2) were used to amplify the 
entire APe gene. 
Table 2: All S sets of primers used in PCR for the amplification of the entire APC gene. 
APC Anticipated
Primer Primer















































5' -cccaaagggaaaagtcacaa -3' 
5' -agcagcagcagcttgatgta-3' 
















APCS 1309 bp 
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A 25ul PCR reaction mixture was used in the PCR assays carried out. Where 
necessary, increment in the PCR reaction mixture was also applied throughout the research 
with appropriate adjustment to the volume of ingredients in mixture. The proper amount 
ofeach ingredient to a peR reaction mixture (of251l1 volume reaction) is as follows (Table 
3). 
Table 3: The amount of each ingredient to a PCR reaction mixture (25111 volume reaction). 
Ingredient Volume (Ill) 
Template DNA 2.00 
5X GoTaq1M PCR buffer (with 7.5 mM MgCh) (Promega, USA) 5.00 
10 mM dNTP Mix (Promega, USA) 0.50 
25 pmoVll1 Forward Primer 1.00 
25 PmoVll1 Reverse Primer 1.00 
5 Villi GoTaq1M DNA Polymerase (Promega, USA) 0.10 
Sterile ultrapure water 15.40 
In monitoring PCR validity, negative control was included in the PCR protocol 
where the template DNA was replaced with sterile ultrapure water. 
The thermal cycling programme was mostly 30 or 35 cycles, and PCR was done 
using the thennal cycler of Perkin Elmer (Model No. 2400), with the amplification 
parameters as indicated in Table 4. 
Table 4: Amplification parameters for PCR protocol. 
Stages Temperature Duration 
Initial Denaturation 2 minutes 
Denaturation 30 seconds 
Annealing Varies on primer set employed 1 minutes 
Extension 72°C 1 minute 30 seconds 
Final extension 72 °c 10 minutes 
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3.1.3 Reverse Transcription-Polymerase Chain Reaction (RT-PCR) 
Procurement of the tumour APe eDNA fragment was carried out via RT-PCR. A 
two-step RT-PCR encompassing a first strand cDNA synthesis and a subsequent PCR was 
perfbnned. 
3.1.3.1 First strand cDNA synthesis 
Total RNA derived from tumour colon tissue requires conversion into cDNA for 
amplification via PCR. First strand cDNA synthesis was performed according to 
manufacturer's protocol (Life Technologies Technical Product Infonnation). The 
procedures that yielded 20 I.d of cDNA reaction volume is as follows: One micro litre of 
100 ng oligo dT, 2 ~I of 1 - 5 ng total RNA and 1 0.5 ~l of nuclease free water were added 
into a nuclease free micro centrifuge tube. The mixture was heated up to 70°C for 10 
minutes and followed by a quick chill on ice prior to a brief spin down. Thereafter, 4 ~l of 
5X MMLV Reverse Transcriptase buffer, 1 ~l of 10 mM dNTP Mix and 0.5 ~l RNase 
inhibitor were added to the early mixture. The content of the micro centrifuge tube was 
gently mixed and incubated at 42°C for 2 minutes. Then, 1 ~l of MMLV Reverse 
Transcriptase was added and mixed by pipetting gently up and down. The cDNA 
reaction mixture was consequently incubated at 42°C for 50 minutes, and fmally 
inactivated by heating at 70°C for 15 minutes. The resulting cDNA which serves as the 
template for PCR reaction was then stored at -80°C. Subsequent PCR protocol was 
nned as described previously. 
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.2.4 Gel Extraction 
Prior to downstream applications (PCR, RT -PCR, Ligation and RE Digestion), the 
products were purified and extracted using Viogene Gel_MTM Gel Extraction System 
.# EG1001, Viogene-Biotek Corporation, USA) by following the manufacturer's 
protocol. The protocol (Spin Method) is as fo Hows: A sterile, sharp scalpel blade was 
used to excise the gel slice containing DNA fragment of interest. The gel slice (50-200 
mg) was placed into a sterile 1.5 ml micro centrifuge tube. Half a millilitre of GEX Buffer 
as added and then incubated at 60°C for 10 minutes. The content was mixed by 
inverting every 1 - 2 minutes during incubation. Dissolved gel mixture was placed onto 
Gel_MlM column in a Collection Tube and subjected to centrifugation at 13000 rpm for 60 
seconds. The flow-through was discarded and the column was subsequently washed with 
O.S ml of WF Buffer and with 0.7 ml WS Buffer accordingly. Centrifugation for 60 
seconds at 13000 rpm was performed after each washing. Then, the ethanol residue was 
reDX)ved by further centrifugation at 13000 rpm for 3 minutes. DNA elution was then 
canied out where the column was placed onto a new 1.5 ml centrifuge tube with further 
addition of 30 III of ultrapure water. The column was left to stand for 2 minutes and 
centrifugation was then applied at 13000 rpm for 2 minutes. The purified DNA 
flow-through was stored at -20°C and is applicable for downstream applications and 
analysis. 
3.2.5 Subcloning of tumour APe cDNA 
The tumour APe cDNA fragments were subcloned using Promega pGEM®-T Easy 
ector System, encompassing ligation and transformation procedures. 
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Standard Positive Background 
Reaction Control Control 
Ligation was carried out initially to introduce the tumour APe cDNA fragments 
the pGE~-T Easy Vector. Positive control (using Control Insert DNA provided by 
manufacturer) and background control (without PCR product or Control Insert DNA) 
performed concurrently to access the performance of the vector system used. Prior 
to ligation, the pGE~-T Easy Vector and Control Insert DNA tubes were briefly 
centrifuged. The 2X Rapid Ligation Buffer were vortexed vigorously before use. The 
ligation reactions set up is shown in Table 5. 
Table 5: The ligation reaction mixture. 
Reagents 
2X Ra~id Ligation Buffer, T4 DNA ligase 
pGEM®-T Easy Vector (5Ong) 
PCRproduct 
Control Insert DNA 
T4 DNA Ligase (3 Weiss unitS/ill) 
Deionized water to a final volume of 
The reactions were mixed by pipetting and subjected to one-hour incubation at 
room temperature. Transformation was then performed using E. coli JMI09 competent 
Us. prepared according to the protocol by Sambrook et at. (1989). Basically, the 
ligation reactions earlier were centrifuged. Two microlitres of each ligation reactions 
were added into 1.5 ml micro centrifuge tubes placed on ice. The frozen JMI09 
competent cells were removed from -80°C storage, thawed in an ice bath, and mixed by 
gentle flicking. Fifty to a hundred microlitres of cells were added into each 1.5ml tube 
accordingly, mixed gently and iced for 20 minutes. Then, each reaction tubes were 
beat-sbocked for 45-50 seconds in a water bath at exactly 42°C and returned to ice for 
_ther 2 minutes. Nine hundred and fifty microlitres room temperature SOC medium 
added to the ligation reactions, followed by incubation at 37°C for 1.5 hour with 
14 
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IIbIlkDllg at around 150 rpm Subsequently, 100111 of each transformation culture was 
onto LB/ampicilinllPTGIX-Gal plates prepared earlier and then incubated overnight 
.6 Screening Transformants for Inserts 
Recombinant clones are identified via blue-white screening on IPTGIX-Gal plates. 
Successful cloning introduces an insert in pGEM® -T Easy Vector and interrupts the 
J-pIactosidase coding sequence. Therefore, clones containing the desired PCR products 
produce white colonies, excluding PCR fragments that are cloned in-frame with the lacZ 
sene or mutation occurrences, as commented by the manufacturer. Single white colonies 
suspected ofharbouring tumour APe fragments were inoculated into 5 ml of LB broth and 
incubated overnight with shaking at 200 rpm. Plasmid isolation, and followed by PCR 
then carried out to verify the presence ofcloned inserts of tumour APe cDNAs . 
•7 Restricdon Enzyme (RE) Analysis 
RE digestion assay was perfonned on all eight fragments of both the nonnal and 
Comparative analysis was done for both the normal and tumour RE 
1J8Ita1:lS generated. The assay was carried out using enzymes including AluI, HaeIII, 
H~ HilleII, HpaII, MhoI, NdeI, RsaI, TaqI, and Tru9I. Types of enzymes used were 
ific tOr eaeh fragment, depending on the APe restriction sites identified theoretically 
the APe coding sequence retrieved from GenBank resource (Accession number 
8). 
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